This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bioage Labs, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kevin Wilhelmsen: Innovator in Inflammation Research
Introduction
Kevin Wilhelmsen is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of inflammation research, particularly through his innovative patent.
Latest Patents
Kevin holds a patent for "Inhibitors of NLRP3 Inflammasome." This patent represents his work in developing potential therapeutic agents that target the NLRP3 inflammasome, which plays a crucial role in inflammatory diseases. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Kevin is currently employed at BioAge Labs, Inc., a company dedicated to developing therapies that target aging and age-related diseases. His work at BioAge Labs has positioned him as a key player in the intersection of biotechnology and inflammation research.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues such as Shijun Yan and George D. Hartman. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field.
Conclusion
Kevin Wilhelmsen's innovative work in inflammation research and his patent for inhibitors of the NLRP3 inflammasome highlight his significant contributions to medical science. His role at BioAge Labs, Inc. and collaborations with other experts underscore his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile